Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Recommendation of Hold by Analysts

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) have earned an average rating of “Hold” from the nine analysts that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price objective among […]

Related Keywords

Hong Kong ,United States ,Canada ,America ,Piper Sandler ,News Ratings For Enanta Pharmaceuticals Daily ,Analyst Recommendations For Enanta Pharmaceuticals ,Tower Research Capital ,Institutional Investors Weigh In On Enanta Pharmaceuticals ,Enanta Pharmaceuticals Company Profile ,Jpmorgan Chase Co ,Enanta Pharmaceuticals Inc ,Securities Exchange Commission ,Royal Bank ,Hong Kong Ltd ,Enanta Pharmaceuticals ,Nasdaq ,Mutual Of America Capital Management ,Enanta Pharmaceuticals Stock ,Get Rating ,Exchange Commission ,Financial Advisors ,Research Capital ,Kong Ltd ,America Capital Management ,Enanta Pharmaceuticals Daily ,Nasdaq Enta ,Enta ,Medical ,Ratings ,Consensus ,